- A provision buried in the fiscal bill passed earlier this month gives Amgen, the world's largest biotechnology firm, more time to sell a lucrative kidney dialysis drug without price restraints. http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html?nl=todaysheadlines&emc=edit_th_20130120&_r=0 57 comments politics
- Congress Gives $500 Million to Giant Pharma Firm Amgen in Line Hidden in Fiscal Cliff Bill http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html?hp 121 comments politics
- Big Senate Gift to Drug Maker: Just two weeks after pleading guilty in a major fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup when Lawmakers inserted a paragraph into the “fiscal cliff” bill that strongly favored one of its drugs http://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html 8 comments politics
Linking pages
- Orrin Hatch Defends Costly Amgen Provision In Fiscal Cliff Deal | HuffPost Latest News http://www.huffingtonpost.com/2013/02/02/fiscal-cliff-deal-amgen-hatch_n_2607175.html 5 comments
- What the Small Player Can Expect When Using a Lobbyist - The New York Times http://www.nytimes.com/2013/01/26/your-money/what-the-small-player-can-expect-when-using-a-lobbyist.html?pagewanted=all&src=recg 0 comments
Linked pages
- How Insurers Exploited Medicare Advantage for Billions - The New York Times https://www.nytimes.com/2022/10/08/upshot/medicare-advantage-fraud-allegations.html 521 comments
- https://www.nytimes.com/2022/11/03/upshot/private-medicare-misleading-marketing.html 13 comments
- Medicare Advantage Plans Often Deny Needed Care, Federal Report Finds - The New York Times https://www.nytimes.com/2022/04/28/health/medicare-advantage-plans-report.html 12 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: Medicare Pricing Delay is Political Win for Amgen, Drug Maker - The New York Times
See how to search.